The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men

Annals of Clinical Biochemistry

Volumn 50, Issue 1, 2013, Pages 39-46

  Chew Harris, Janice S C ^a   Florkowski, Christopher M ^b   George, Peter M ^b   Elmslie, Jane L ^b   Endre, Zoltan H ^c  

^a Medlab South Ltd   (New Zealand)

^b CANTERBURY HEALTH LABORATORIES   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYSTATIN C; PENTETATE TECHNETIUM TC 99M;

ADULT; ARTICLE; BIO ELECTRICAL IMPEDANCE; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; MEASUREMENT; MUSCLE MASS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADOLESCENT; ADULT; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CREATININE; CYSTATIN C; ELECTRIC IMPEDANCE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; PENTETIC ACID;

EID: 84880292110     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2012.011241     Document Type: Article

References (52)

1. National Kidney Foundation Guidelines. See http://www.kidney.org.professionals/kdoqi/guidelines.cfm (last checked 9 August 2011)
2. Mathew TH, Johnson DM, Jones GR. Australasian Creatinine Consensus Working Group: chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust 2007;187:459-63
3. Lin J, Knight EL, Hogan ML, Singh AK. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 2003;14:2573-80
4. Abrahamson M, Olafsson I, Palsdottir A, et al. Structure and expression of the human cystatin C gene. Biochem J 1990;268:287-94
5. Tenstad O, Roald AB, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 1996;56:409-14
6. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 2002;48:699-707
7. Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995;47:312-18
8. Dharnidharka VR, Kwon C, Stevens G. Serum Cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002;40:221-6
9. Roos JF, Doust J, Tett SE, Kirkpatrick CMJ. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children-a meta-analysis. Clin Biochem 2007;40:383-91
10. Chew JSC, Saleem M, Florkowski CM, George PM. Cystatin C-a paradigm of evidence-based laboratory medicine. Clin Biochem Rev 2008;29:47-62
11. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004;65:1416-21
12. Fricker M, Wiesli P, Brändle M, Schwegler B, Schmid C. Impact of thyroid dysfunction on serum cystatin C. Kidney Int 2003;63:1944-7
13. Wiesli P, Schwegler B, Spinas GS, Schmid C. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta 2003;338:87-90
14. Muntner P, Winston J, Uribarri J, Mann D, Fox CS. Overweight, obesity, and elevated cystatin C levels in adults in the United States. Am J Med 2008;121:341-8
15. Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009;75:652-60
16. Vupputuri S, Fox CS, Coresh J, Woodwark M, Muntner P. Differential estimation of CKD using creatinine-versus cystatin C-based estimating equations by category of body mass index. Am J Kidney Dis 2009;53:993-1001
17. Ognibene A, Mannucci E, Caldini A, et al. Cystatin C reference values and aging. Clin Biochem 2006;39:658-61
18. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049-60
19. Menon V, Schlipak MG, Wang X, et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med 2007;147:19-27
20. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-71
21. Kiebzak GM, Leamy LJ, Pierson LM, Nord RH, Zhang ZY. Measurement precision of body composition variables using the lunar DPX-L densitometer. J Clin Densitom 2000;3:35-41
22. N Latex Cystatin C Package insert OQNM G13 E1401 (807). Siemens Healthcare Diagnostics Products GmBH. April 2008
23. Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 2005;142:497-505
24. Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997;43:1016-22
25. Creatinine Plus Method. Packet insert. Roche Diagnostic GmBH (Mannheim), Indianapolis, IN. Catalogue number: 11875566 216 and 11875582 216
26. Peake M, Whiting M. Measurement of serum creatinine-current status and future goals. Clin Biochem Rev 2006;27:173-84
27. Tina-quant C-Reactive Protein Gen 3 Packet Insert. Roche Diagnostic GmBH (Mannheim), Indianapolis, IN. Catalogue number: 04995554 190
28. Total Protein in Urine/Cerebrospinal Fluid. Packet Insert. Roche Diagnostic GmBH (Mannheim), Indianapolis, IN. Catalogue number: 11877801 190
29. Le Bricon T, Thervet E, Benlakehal M, Bousquet B, Legendre C, Erlich D. Changes in plasma cystatin C after renal transplantation and acute rejection in adults. Clin Chem 1999;45:2243-9
30. Hoek FJ, Kemperman FAW, Krediet RT. A comparison between cystatin C, plasma creatinine and the cockcroft and gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003;18:2024-31
31. Larsson A, Malm J, Grubb A, Hansson LO. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 2004;64:25-30
32. MacIsaac RJ, Tsalamandris C, Thomas MC, et al. Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C-and creatinine-based methods. Diabetologia 2006;49:1686-9
33. Rule AD, Bergstralh EJ, Slezak JM, Bergert J, Larson TS. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int 2006;69:399-405
34. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3, 418 individuals with CKD. Am J Kidney Dis 2008;51:395-406
35. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54
36. Levey AS, Stevens LA, Schmid CH, et al. Chronic kidney disease epidemiology (CKD-EPI). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12
37. Kim J, Heshka S, Gallagher D, et al. Intermuscular adipose tissue-free skeletal muscle mass: estimation by dual-energy X-ray absorptiometry in adults. J Appl Physiol 2004;97:655-60
38. Edington J, Thorogood M, Geekie M, Ball M, Mann JI. Assessment of nutritional intake using dietary records with estimated weights. J Hum Nutr Diet 1989;2:577-81
39. Hollis S. Analysis of method comparison studies. Ann Clin Biochem 1996;33:1-4
40. Saleem M, Florkowski CM, George PM, Woltersdorf WWW.Comparison of two prediction equations with radionuclide glomerular filtration rate: validation in routine use. Ann Clin Biochem 2006;43:309-13
41. Dupond WD, Plummer WD. PS power and sample size program available for free on internet. Control Clin Trials 1997;18:274
42. Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk. Clin Chem 2009;55:1932-43
43. Perkins BA, Nelson RG, Ostrander BEP, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol 2005;16:1404-12
44. Pucci L, Triscornia S, Lucchesi D, et al. Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem 2007;53:480-8
45. Naour N, Fellahi S, Renucci JF, et al. Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity 2009;17:2121-6
46. Bengtsson E, To F, Håkansson K, et al. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005;25:2151-6
47. Lafarge JC, Naour N, Clément K, Guerre-Millo M. Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 2010;92:1580-6
48. Muntner P, Vupputuri S, Coresh J, Uribarri J, Fox CS. Metabolic abnormalities are present in adults with elevated serum cystatin C. Kidney Int 2009;76:81-8
49. Muntner P, Mann D, Winston J, Sameer B, Farkouh ME. Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease. Am J Cardiol 2008;102:54-7
50. Rule AD, Bailey KR, Schwartz GL, Khosla S, Lieske JC, Melton LJ III. For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 2009;75:1071-8
51. Macdonald JH, Marcora SM, Kumwenda MJ, et al. The relationship between estimated glomerular filtration rate, demographic and anthropometric variables is mediated by muscle mass in non-diabetic patients with chronic kidney disease. Nephrol Dial Transplant 2006;21:3488-94
52. Macdonald J, Marcora S, Jibani M, et al. GFR estimation using cystatin C is not independent of body composition. Am J Kidney Dis 2006;48:712-9